Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Inderetic 80mg/2.5mg capsules
0204000Q0BBAAAA
|
Inderetic | Propranolol hydrochloride with diuretic | Cardiovascular System | No data available |
|
Inderex 160mg/5mg modified-release capsules
0204000Q0BCAAAB
|
Inderex | Propranolol hydrochloride with diuretic | Cardiovascular System | No data available |
|
Propranolol 160mg MR / Bendroflumethiazide 5mg caps
0204000Q0AAABAB
|
Propranol hydrochloride with diuretic | Propranolol hydrochloride with diuretic | Cardiovascular System | No data available |
|
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules
0204000Q0AAAAAA
|
Propranol hydrochloride with diuretic | Propranolol hydrochloride with diuretic | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.